aluates Reports

$ 0.0

Automative

Global Biologic Medication in COVID-19 Market Research Report 2025

Published Date: July 2025

Report Code: QYRE-Auto-17W5963

Global Biologic Medication in COVID 19 Market Insights Forecast to 2028

BUY CHAPTERS

Global Biologic Medication in COVID-19 Market Research Report 2025

Code: QYRE-Auto-17W5963

Report

July 2025

Pages:84

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Roche

Sanofi

Novartis

Merck

Bayer

Shutaishen

Biogen

Regeneron Pharmaceuticals

Vir Biotech

Junshi Biosciences

Anke Biotechnology

OncoImmune, Inc.

Biologic Medication in COVID-19 Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Biologic Medication in COVID-19 Market

The global market for Biologic Medication in COVID-19 was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

According to China"s clinical trials of COVID-19 treatment, the number of chemical drugs accounted for the highest proportion, followed by biological drugs, cell therapy, vaccines, and traditional Chinese medicine. Among the biological drugs, IL-6 related monoclonal antibodies (anti-inflammatory) account for the largest proportion, including tocilizumab and Sarilumab. This report focuses on the investigation and analysis of biologic medication and predicts the future market development of biopharmaceuticals under the influence of COVID-19. Biological drugs are mainly divided into two categories: neutralizing antibodies and anti-inflammatory drugs. The main subdivisions include: IL-6, C5a, CD147, PD-1 and Interferon (beta-1a), etc.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Biologic Medication in COVID-19, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biologic Medication in COVID-19.

The Biologic Medication in COVID-19 market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Biologic Medication in COVID-19 market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Biologic Medication in COVID-19 companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Biologic Medication in COVID-19 Market Report

Report Metric	Details
Report Name	Biologic Medication in COVID-19 Market
CAGR	5%
Segment by Type	Neutralizing Antibodies Anti-inflammatory Drugs
Segment by Application	COVID-19 Influenza Malaria Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Roche, Sanofi, Novartis, Merck, Bayer, Shutaishen, Biogen, Regeneron Pharmaceuticals, Vir Biotech, Junshi Biosciences, Anke Biotechnology, OncoImmune
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biologic Medication in COVID-19 company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Biologic Medication in COVID-19 Market report?

Ans: The main players in the Biologic Medication in COVID-19 Market are Roche, Sanofi, Novartis, Merck, Bayer, Shutaishen, Biogen, Regeneron Pharmaceuticals, Vir Biotech, Junshi Biosciences, Anke Biotechnology, OncoImmune

What are the Application segmentation covered in the Biologic Medication in COVID-19 Market report?

Ans: The Applications covered in the Biologic Medication in COVID-19 Market report are COVID-19, Influenza, Malaria, Others

What are the Type segmentation covered in the Biologic Medication in COVID-19 Market report?

Ans: The Types covered in the Biologic Medication in COVID-19 Market report are Neutralizing Antibodies, Anti-inflammatory Drugs

Recommended Reports

COVID-19 Therapies

Biologics & Biosimilars

Virus Diagnostics

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Biologic Medication in COVID-19 Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Neutralizing Antibodies

1.2.3 Anti-inflammatory Drugs

1.3 Market by Application

1.3.1 Global Biologic Medication in COVID-19 Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 COVID-19

1.3.3 Influenza

1.3.4 Malaria

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Biologic Medication in COVID-19 Market Perspective (2020-2031)

2.2 Global Biologic Medication in COVID-19 Growth Trends by Region

2.2.1 Global Biologic Medication in COVID-19 Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Biologic Medication in COVID-19 Historic Market Size by Region (2020-2025)

2.2.3 Biologic Medication in COVID-19 Forecasted Market Size by Region (2026-2031)

2.3 Biologic Medication in COVID-19 Market Dynamics

2.3.1 Biologic Medication in COVID-19 Industry Trends

2.3.2 Biologic Medication in COVID-19 Market Drivers

2.3.3 Biologic Medication in COVID-19 Market Challenges

2.3.4 Biologic Medication in COVID-19 Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Biologic Medication in COVID-19 Players by Revenue

3.1.1 Global Top Biologic Medication in COVID-19 Players by Revenue (2020-2025)

3.1.2 Global Biologic Medication in COVID-19 Revenue Market Share by Players (2020-2025)

3.2 Global Biologic Medication in COVID-19 Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Biologic Medication in COVID-19 Revenue

3.4 Global Biologic Medication in COVID-19 Market Concentration Ratio

3.4.1 Global Biologic Medication in COVID-19 Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Biologic Medication in COVID-19 Revenue in 2024

3.5 Global Key Players of Biologic Medication in COVID-19 Head office and Area Served

3.6 Global Key Players of Biologic Medication in COVID-19, Product and Application

3.7 Global Key Players of Biologic Medication in COVID-19, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Biologic Medication in COVID-19 Breakdown Data by Type

4.1 Global Biologic Medication in COVID-19 Historic Market Size by Type (2020-2025)

4.2 Global Biologic Medication in COVID-19 Forecasted Market Size by Type (2026-2031)

5 Biologic Medication in COVID-19 Breakdown Data by Application

5.1 Global Biologic Medication in COVID-19 Historic Market Size by Application (2020-2025)

5.2 Global Biologic Medication in COVID-19 Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Biologic Medication in COVID-19 Market Size (2020-2031)

6.2 North America Biologic Medication in COVID-19 Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Biologic Medication in COVID-19 Market Size by Country (2020-2025)

6.4 North America Biologic Medication in COVID-19 Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Biologic Medication in COVID-19 Market Size (2020-2031)

7.2 Europe Biologic Medication in COVID-19 Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Biologic Medication in COVID-19 Market Size by Country (2020-2025)

7.4 Europe Biologic Medication in COVID-19 Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Biologic Medication in COVID-19 Market Size (2020-2031)

8.2 Asia-Pacific Biologic Medication in COVID-19 Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Biologic Medication in COVID-19 Market Size by Region (2020-2025)

8.4 Asia-Pacific Biologic Medication in COVID-19 Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Biologic Medication in COVID-19 Market Size (2020-2031)

9.2 Latin America Biologic Medication in COVID-19 Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Biologic Medication in COVID-19 Market Size by Country (2020-2025)

9.4 Latin America Biologic Medication in COVID-19 Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Biologic Medication in COVID-19 Market Size (2020-2031)

10.2 Middle East & Africa Biologic Medication in COVID-19 Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Biologic Medication in COVID-19 Market Size by Country (2020-2025)

10.4 Middle East & Africa Biologic Medication in COVID-19 Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Roche

11.1.1 Roche Company Details

11.1.2 Roche Business Overview

11.1.3 Roche Biologic Medication in COVID-19 Introduction

11.1.4 Roche Revenue in Biologic Medication in COVID-19 Business (2020-2025)

11.1.5 Roche Recent Development

11.2 Sanofi

11.2.1 Sanofi Company Details

11.2.2 Sanofi Business Overview

11.2.3 Sanofi Biologic Medication in COVID-19 Introduction

11.2.4 Sanofi Revenue in Biologic Medication in COVID-19 Business (2020-2025)

11.2.5 Sanofi Recent Development

11.3 Novartis

11.3.1 Novartis Company Details

11.3.2 Novartis Business Overview

11.3.3 Novartis Biologic Medication in COVID-19 Introduction

11.3.4 Novartis Revenue in Biologic Medication in COVID-19 Business (2020-2025)

11.3.5 Novartis Recent Development

11.4 Merck

11.4.1 Merck Company Details

11.4.2 Merck Business Overview

11.4.3 Merck Biologic Medication in COVID-19 Introduction

11.4.4 Merck Revenue in Biologic Medication in COVID-19 Business (2020-2025)

11.4.5 Merck Recent Development

11.5 Bayer

11.5.1 Bayer Company Details

11.5.2 Bayer Business Overview

11.5.3 Bayer Biologic Medication in COVID-19 Introduction

11.5.4 Bayer Revenue in Biologic Medication in COVID-19 Business (2020-2025)

11.5.5 Bayer Recent Development

11.6 Shutaishen

11.6.1 Shutaishen Company Details

11.6.2 Shutaishen Business Overview

11.6.3 Shutaishen Biologic Medication in COVID-19 Introduction

11.6.4 Shutaishen Revenue in Biologic Medication in COVID-19 Business (2020-2025)

11.6.5 Shutaishen Recent Development

11.7 Biogen

11.7.1 Biogen Company Details

11.7.2 Biogen Business Overview

11.7.3 Biogen Biologic Medication in COVID-19 Introduction

11.7.4 Biogen Revenue in Biologic Medication in COVID-19 Business (2020-2025)

11.7.5 Biogen Recent Development

11.8 Regeneron Pharmaceuticals

11.8.1 Regeneron Pharmaceuticals Company Details

11.8.2 Regeneron Pharmaceuticals Business Overview

11.8.3 Regeneron Pharmaceuticals Biologic Medication in COVID-19 Introduction

11.8.4 Regeneron Pharmaceuticals Revenue in Biologic Medication in COVID-19 Business (2020-2025)

11.8.5 Regeneron Pharmaceuticals Recent Development

11.9 Vir Biotech

11.9.1 Vir Biotech Company Details

11.9.2 Vir Biotech Business Overview

11.9.3 Vir Biotech Biologic Medication in COVID-19 Introduction

11.9.4 Vir Biotech Revenue in Biologic Medication in COVID-19 Business (2020-2025)

11.9.5 Vir Biotech Recent Development

11.10 Junshi Biosciences

11.10.1 Junshi Biosciences Company Details

11.10.2 Junshi Biosciences Business Overview

11.10.3 Junshi Biosciences Biologic Medication in COVID-19 Introduction

11.10.4 Junshi Biosciences Revenue in Biologic Medication in COVID-19 Business (2020-2025)

11.10.5 Junshi Biosciences Recent Development

11.11 Anke Biotechnology

11.11.1 Anke Biotechnology Company Details

11.11.2 Anke Biotechnology Business Overview

11.11.3 Anke Biotechnology Biologic Medication in COVID-19 Introduction

11.11.4 Anke Biotechnology Revenue in Biologic Medication in COVID-19 Business (2020-2025)

11.11.5 Anke Biotechnology Recent Development

11.12 OncoImmune

11.12.1 OncoImmune Company Details

11.12.2 OncoImmune Business Overview

11.12.3 OncoImmune Biologic Medication in COVID-19 Introduction

11.12.4 OncoImmune Revenue in Biologic Medication in COVID-19 Business (2020-2025)

11.12.5 OncoImmune Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Roche

Sanofi

Novartis

Merck

Bayer

Shutaishen

Biogen

Regeneron Pharmaceuticals

Vir Biotech

Junshi Biosciences

Anke Biotechnology

OncoImmune, Inc.

List of Tables

Table 1. Global Biologic Medication in COVID-19 Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Neutralizing Antibodies

Table 3. Key Players of Anti-inflammatory Drugs

Table 4. Global Biologic Medication in COVID-19 Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Biologic Medication in COVID-19 Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Biologic Medication in COVID-19 Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Biologic Medication in COVID-19 Market Share by Region (2020-2025)

Table 8. Global Biologic Medication in COVID-19 Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Biologic Medication in COVID-19 Market Share by Region (2026-2031)

Table 10. Biologic Medication in COVID-19 Market Trends

Table 11. Biologic Medication in COVID-19 Market Drivers

Table 12. Biologic Medication in COVID-19 Market Challenges

Table 13. Biologic Medication in COVID-19 Market Restraints

Table 14. Global Biologic Medication in COVID-19 Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Biologic Medication in COVID-19 Market Share by Players (2020-2025)

Table 16. Global Top Biologic Medication in COVID-19 Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biologic Medication in COVID-19 as of 2024)

Table 17. Ranking of Global Top Biologic Medication in COVID-19 Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Biologic Medication in COVID-19 Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Biologic Medication in COVID-19, Headquarters and Area Served

Table 20. Global Key Players of Biologic Medication in COVID-19, Product and Application

Table 21. Global Key Players of Biologic Medication in COVID-19, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Biologic Medication in COVID-19 Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Biologic Medication in COVID-19 Revenue Market Share by Type (2020-2025)

Table 25. Global Biologic Medication in COVID-19 Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Biologic Medication in COVID-19 Revenue Market Share by Type (2026-2031)

Table 27. Global Biologic Medication in COVID-19 Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Biologic Medication in COVID-19 Revenue Market Share by Application (2020-2025)

Table 29. Global Biologic Medication in COVID-19 Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Biologic Medication in COVID-19 Revenue Market Share by Application (2026-2031)

Table 31. North America Biologic Medication in COVID-19 Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Biologic Medication in COVID-19 Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Biologic Medication in COVID-19 Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Biologic Medication in COVID-19 Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Biologic Medication in COVID-19 Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Biologic Medication in COVID-19 Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Biologic Medication in COVID-19 Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Biologic Medication in COVID-19 Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Biologic Medication in COVID-19 Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Biologic Medication in COVID-19 Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Biologic Medication in COVID-19 Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Biologic Medication in COVID-19 Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Biologic Medication in COVID-19 Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Biologic Medication in COVID-19 Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Biologic Medication in COVID-19 Market Size by Country (2026-2031) & (US$ Million)

Table 46. Roche Company Details

Table 47. Roche Business Overview

Table 48. Roche Biologic Medication in COVID-19 Product

Table 49. Roche Revenue in Biologic Medication in COVID-19 Business (2020-2025) & (US$ Million)

Table 50. Roche Recent Development

Table 51. Sanofi Company Details

Table 52. Sanofi Business Overview

Table 53. Sanofi Biologic Medication in COVID-19 Product

Table 54. Sanofi Revenue in Biologic Medication in COVID-19 Business (2020-2025) & (US$ Million)

Table 55. Sanofi Recent Development

Table 56. Novartis Company Details

Table 57. Novartis Business Overview

Table 58. Novartis Biologic Medication in COVID-19 Product

Table 59. Novartis Revenue in Biologic Medication in COVID-19 Business (2020-2025) & (US$ Million)

Table 60. Novartis Recent Development

Table 61. Merck Company Details

Table 62. Merck Business Overview

Table 63. Merck Biologic Medication in COVID-19 Product

Table 64. Merck Revenue in Biologic Medication in COVID-19 Business (2020-2025) & (US$ Million)

Table 65. Merck Recent Development

Table 66. Bayer Company Details

Table 67. Bayer Business Overview

Table 68. Bayer Biologic Medication in COVID-19 Product

Table 69. Bayer Revenue in Biologic Medication in COVID-19 Business (2020-2025) & (US$ Million)

Table 70. Bayer Recent Development

Table 71. Shutaishen Company Details

Table 72. Shutaishen Business Overview

Table 73. Shutaishen Biologic Medication in COVID-19 Product

Table 74. Shutaishen Revenue in Biologic Medication in COVID-19 Business (2020-2025) & (US$ Million)

Table 75. Shutaishen Recent Development

Table 76. Biogen Company Details

Table 77. Biogen Business Overview

Table 78. Biogen Biologic Medication in COVID-19 Product

Table 79. Biogen Revenue in Biologic Medication in COVID-19 Business (2020-2025) & (US$ Million)

Table 80. Biogen Recent Development

Table 81. Regeneron Pharmaceuticals Company Details

Table 82. Regeneron Pharmaceuticals Business Overview

Table 83. Regeneron Pharmaceuticals Biologic Medication in COVID-19 Product

Table 84. Regeneron Pharmaceuticals Revenue in Biologic Medication in COVID-19 Business (2020-2025) & (US$ Million)

Table 85. Regeneron Pharmaceuticals Recent Development

Table 86. Vir Biotech Company Details

Table 87. Vir Biotech Business Overview

Table 88. Vir Biotech Biologic Medication in COVID-19 Product

Table 89. Vir Biotech Revenue in Biologic Medication in COVID-19 Business (2020-2025) & (US$ Million)

Table 90. Vir Biotech Recent Development

Table 91. Junshi Biosciences Company Details

Table 92. Junshi Biosciences Business Overview

Table 93. Junshi Biosciences Biologic Medication in COVID-19 Product

Table 94. Junshi Biosciences Revenue in Biologic Medication in COVID-19 Business (2020-2025) & (US$ Million)

Table 95. Junshi Biosciences Recent Development

Table 96. Anke Biotechnology Company Details

Table 97. Anke Biotechnology Business Overview

Table 98. Anke Biotechnology Biologic Medication in COVID-19 Product

Table 99. Anke Biotechnology Revenue in Biologic Medication in COVID-19 Business (2020-2025) & (US$ Million)

Table 100. Anke Biotechnology Recent Development

Table 101. OncoImmune Company Details

Table 102. OncoImmune Business Overview

Table 103. OncoImmune Biologic Medication in COVID-19 Product

Table 104. OncoImmune Revenue in Biologic Medication in COVID-19 Business (2020-2025) & (US$ Million)

Table 105. OncoImmune Recent Development

Table 106. Research Programs/Design for This Report

Table 107. Key Data Information from Secondary Sources

Table 108. Key Data Information from Primary Sources

Table 109. Authors List of This Report

List of Figures

Figure 1. Biologic Medication in COVID-19 Picture

Figure 2. Global Biologic Medication in COVID-19 Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Biologic Medication in COVID-19 Market Share by Type: 2024 VS 2031

Figure 4. Neutralizing Antibodies Features

Figure 5. Anti-inflammatory Drugs Features

Figure 6. Global Biologic Medication in COVID-19 Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Biologic Medication in COVID-19 Market Share by Application: 2024 VS 2031

Figure 8. COVID-19 Case Studies

Figure 9. Influenza Case Studies

Figure 10. Malaria Case Studies

Figure 11. Others Case Studies

Figure 12. Biologic Medication in COVID-19 Report Years Considered

Figure 13. Global Biologic Medication in COVID-19 Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 14. Global Biologic Medication in COVID-19 Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Biologic Medication in COVID-19 Market Share by Region: 2024 VS 2031

Figure 16. Global Biologic Medication in COVID-19 Market Share by Players in 2024

Figure 17. Global Top Biologic Medication in COVID-19 Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biologic Medication in COVID-19 as of 2024)

Figure 18. The Top 10 and 5 Players Market Share by Biologic Medication in COVID-19 Revenue in 2024

Figure 19. North America Biologic Medication in COVID-19 Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. North America Biologic Medication in COVID-19 Market Share by Country (2020-2031)

Figure 21. United States Biologic Medication in COVID-19 Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Canada Biologic Medication in COVID-19 Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Biologic Medication in COVID-19 Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Biologic Medication in COVID-19 Market Share by Country (2020-2031)

Figure 25. Germany Biologic Medication in COVID-19 Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. France Biologic Medication in COVID-19 Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. U.K. Biologic Medication in COVID-19 Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Italy Biologic Medication in COVID-19 Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Russia Biologic Medication in COVID-19 Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Nordic Countries Biologic Medication in COVID-19 Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Biologic Medication in COVID-19 Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Biologic Medication in COVID-19 Market Share by Region (2020-2031)

Figure 33. China Biologic Medication in COVID-19 Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Japan Biologic Medication in COVID-19 Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. South Korea Biologic Medication in COVID-19 Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Southeast Asia Biologic Medication in COVID-19 Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. India Biologic Medication in COVID-19 Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Australia Biologic Medication in COVID-19 Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Biologic Medication in COVID-19 Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Biologic Medication in COVID-19 Market Share by Country (2020-2031)

Figure 41. Mexico Biologic Medication in COVID-19 Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Brazil Biologic Medication in COVID-19 Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Biologic Medication in COVID-19 Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Biologic Medication in COVID-19 Market Share by Country (2020-2031)

Figure 45. Turkey Biologic Medication in COVID-19 Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Saudi Arabia Biologic Medication in COVID-19 Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. UAE Biologic Medication in COVID-19 Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Roche Revenue Growth Rate in Biologic Medication in COVID-19 Business (2020-2025)

Figure 49. Sanofi Revenue Growth Rate in Biologic Medication in COVID-19 Business (2020-2025)

Figure 50. Novartis Revenue Growth Rate in Biologic Medication in COVID-19 Business (2020-2025)

Figure 51. Merck Revenue Growth Rate in Biologic Medication in COVID-19 Business (2020-2025)

Figure 52. Bayer Revenue Growth Rate in Biologic Medication in COVID-19 Business (2020-2025)

Figure 53. Shutaishen Revenue Growth Rate in Biologic Medication in COVID-19 Business (2020-2025)

Figure 54. Biogen Revenue Growth Rate in Biologic Medication in COVID-19 Business (2020-2025)

Figure 55. Regeneron Pharmaceuticals Revenue Growth Rate in Biologic Medication in COVID-19 Business (2020-2025)

Figure 56. Vir Biotech Revenue Growth Rate in Biologic Medication in COVID-19 Business (2020-2025)

Figure 57. Junshi Biosciences Revenue Growth Rate in Biologic Medication in COVID-19 Business (2020-2025)

Figure 58. Anke Biotechnology Revenue Growth Rate in Biologic Medication in COVID-19 Business (2020-2025)

Figure 59. OncoImmune Revenue Growth Rate in Biologic Medication in COVID-19 Business (2020-2025)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global COVID 19 Medicine Market Research Report 2024

Covid 19 Therapeutic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Covid 19 Diagnostic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Oral COVID 19 Antiviral Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Chinese Materia Medica for COVID 19 Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Specific Antiviral Drugs for COVID 19 Market

COVID 19 Drug API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

COVID 19 Diagnostic Tests Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Oral Antiviral Medicines for COVID 19 Market Research Report 2024

Covid 19 Diagnostic Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Oral COVID 19 Drug Market Research Report 2025

COVID 19 In Vitro Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

COVID 19 Test Kits Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Covid 19 Rapid Diagnostic Test Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

COVID 19 Inactivated Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

COVID 19 DNA Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Oral COVID 19 Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Remdesivir COVID 19 Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Chloroquine Drug for COVID 19 Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions